(Q34394241)

1 August 2017

1 reference

title

Acetylcholinesterase in Alzheimer's disease (English)

1 reference

1 August 2017

0 references

Talesa VN

1

1 reference

1 August 2017

1 November 2001

1 reference

Mechanisms of Ageing and Development

1 August 2017

1 reference

1 August 2017

122

1 reference

1 August 2017

1961-1969

1 reference

1 August 2017

16

1 reference

Stable complexes involving acetylcholinesterase and amyloid-beta peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils.

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development--a study of molecular forms

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Molecular forms of acetylcholinesterase in senile dementia of Alzheimer type: selective loss of the intermediate (10S) form

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Cerebrospinal fluid cholinesterases in aging and in dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Altered lymphocyte acetylcholinesterase activity in patients with senile dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

The cholinergic hypothesis of geriatric memory dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Amphiphilic and Nonamphiphilic Forms of Torpedo Cholinesterases: II. Electrophoretic Variants and Phosphatidylinositol Phospholipase C-Sensitive and -Insensitive Forms

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Molecular forms of acetylcholinesterase in brain, nerve and muscle: Nature, localization and dynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to Alzheimer's disease beta-protein

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Electron microscopic localization of cholinesterase activity in Alzheimer brain tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Comparison of butyrylcholinesterase and acetylcholinesterase

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Clinical benefits of a new piperidine-class AChE inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Cholinesterases in cerebrospinal fluid. A longitudinal study in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Brain selective inhibition of acetylcholinesterase: a novel approach to therapy for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Distribution of the molecular forms of acetylcholinesterase in human brain: alterations in dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Structural roles of acetylcholinesterase variants in biology and pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Human erythrocyte membrane bound enzyme acetylcholinesterase

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Blood markers in Alzheimer disease: subnormal acetylcholinesterase and butyrylcholinesterase in lymphocytes and erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Cholinesterase-like domains in enzymes and structural proteins: functional and evolutionary relationships and identification of a catalytically essential aspartic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Atypical amyloid (A beta) deposition in the cerebellum in Alzheimer's disease: an immunohistochemical study using end-specific A beta monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Molecular and cellular biology of cholinesterases

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Alzheimer plaques and cortical cholinergic innervation

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Colocalization of cholinesterases with beta amyloid protein in aged and Alzheimer's brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Cognitive enhancement therapy for Alzheimer's disease. The way forward

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Changes in brain cholinesterases in senile dementia of Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Clinical pharmacology of rivastigmine: a new-generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

The amyloid beta-protein of Alzheimer's disease increases acetylcholinesterase expression by increasing intracellular calcium in embryonal carcinoma P19 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the beta-amyloid protein precursor of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

An CSF anamalous molecular form of acetylcholinesterase in demented and non-demented subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

CSF cholinesterase activity in demented and non-demented subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Molecular forms of acetylcholinesterase in subcortical areas of normal and Alzheimer disease brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Cholinesterase enzymes in the blood of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Molecular cloning and construction of the coding region for human acetylcholinesterase reveals a G + C-rich attenuating structure

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Donepezil hydrochloride (E2020) and other acetylcholinesterase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Acetylcholinesterase activity of lymphocytes: an enzyme characteristic of T-cells

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Interaction of fluorescence probes with acetylcholinesterase. Site and specificity of propidium binding

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

The cholinesterases: from genes to proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

Plasma and serum G4 isoenzyme of acetylcholinesterase in patients with Alzheimer-type dementia and vascular dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0047-6374%2801%2900309-8

7 January 2021

10.1016/S0047-6374(01)00309-8

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11589914